This table presents recent patent oppositions filed by Teva Pharmaceutical Industries Ltd against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP4159205Novel Pharmaceutical CompositionNOVARTIS AGNov 13, 2024
EP3628319Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALS, INC.Nov 12, 2024
EP3478286Methods Of Treating Ovarian CancerTESARO INC.Oct 1, 2024
EP3634380Inhibition Of Crystal Growth Of RoflumilastARCUTIS BIOTHERAPEUTICS, INC.Sep 20, 2024
EP3595667Pharmaceutical Compositions Comprising A Jak InhibitorALFASIGMA S.P.A.Sep 17, 2024
EP3494972Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARE COMPANYSep 12, 2024
EP3500299Use Of A Combination Comprising A Btk Inhibitor For Treating CancersBEIGENE, LTD.Sep 12, 2024
EP2425821Pharmaceutical Preparation Containing Oxycodone And NaloxoneEURO-CELTIQUE S.A.Feb 8, 2018
EP2425824Pharmaceutical Preparation Containing Oxycodone And NaloxoneEURO-CELTIQUE S.A.Feb 8, 2018
EP2838513Oral Solid Preparation Comprising Aripiprazole And Method For Producing Oral Solid Preparation Comprising AripiprazoleOTSUKA PHARMACEUTICAL CO., LTD.Jan 5, 2018